Displaying drugs 1451 - 1475 of 2778 in total
Name | Weight | Structure | Description | Categories |
---|---|---|---|---|
Temsirolimus | 1030.2871 C56H87NO16 | A antineoplastic agent used in the treatment of renal cell carcinoma (RCC) that works by inhibiting mTOR. | Mammalian target of rapamycin (mTOR) kinase inhibitors / Protein Kinase Inhibitors | |
Amisulpride | 369.479 C17H27N3O4S | A dopamine D2 receptor antagonist used in the treatment of acute and chronic schizophrenia, and in the prevention and treatment of postoperative nausea and vomiting in adults. | Benzamides and benzamide derivatives | |
Simeprevir | 749.939 C38H47N5O7S2 | A direct-acting antiviral agent that inhibits HCV NS3/4A protease to treat chronic hepatitis C virus (HCV) infection in adults with HCV genotype 1 or 4. | Antivirals for treatment of HCV infections / Protease Inhibitors / Sulfonamides | |
Dapagliflozin | 408.873 C21H25ClO6 | A sodium-glucose cotransporter 2 inhibitor used in the management of type 2 diabetes mellitus. | Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors / Sodium-Glucose Transport Proteins, antagonists & inhibitors / Sodium-Glucose Transporter 2 Inhibitors | |
Saxagliptin | 315.41 C18H25N3O2 | An DPP-4 inhibitor used for the management of type 2 diabetes mellitus. | DPP-IV Inhibitors / Incretins | |
Elacestrant | 458.646 C30H38N2O2 | An estrogen receptor antagonist used to treat ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy. | Antineoplastic Agents / Antineoplastic and Immunomodulating Agents / BCRP/ABCG2 Inhibitors / Cytochrome P-450 CYP2A6 Substrates / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Substrates / Endocrine Therapy / Estrogen Receptor Antagonists / Estrogens, Non-Steroidal / Naphthalenes / OATP2B1/SLCO2B1 substrates / P-glycoprotein inhibitors / Selective Estrogen Receptor Degraders | |
Bazedoxifene | 470.613 C30H34N2O3 | A selective estrogen receptor modulator (SERM) used to treat moderate to severe vasomotor symptoms in menopause and osteoporosis alone or in combination with conjugated estrogens. | Selective Estrogen Receptor Modulators | |
Telavancin | 1755.65 C80H106Cl2N11O27P | An antibacterial agent used in the treatment of complicated skin and skin structure infections and types of hospital-acquired bacterial pneumonia. | Glycopeptide Antibacterials | |
Ambrisentan | 378.428 C22H22N2O4 | A selective type A endothelin receptor antagonist used to treat primary pulmonary arterial hypertension and pulmonary arterial hypertension based on diagnostic classifications. | Antihypertensives for Pulmonary Arterial Hypertension | |
Doxercalciferol | 412.6478 C28H44O2 | A synthetic vitamin D2 analog used to treat secondary hyperparathyroidism in patients with chronic kidney disease with or without therapy of dialysis. | Bone Density Conservation Agents / Vitamin D and Analogues / Vitamins | |
Oxymetholone | 332.484 C21H32O3 | An anabolic steroid used for the treatment of types of anemia, such as acquired aplastic anemia, congenital aplastic anemia, myelofibrosis, and the hypoplastic anemias. | Androstan Derivatives | |
Armodafinil | 273.35 C15H15NO2S | A stimulant used to improve wakefulness in adult patients with excessive sleepiness associated with obstructive sleep apnea, narcolepsy, or shift work disorder. | Centrally Acting Sympathomimetics | |
Etravirine | 435.277 C20H15BrN6O | A non-nucleoside reverse transcriptase inhibitor (NNRTI) used in the treatment of HIV-1 infections in combination with other antiretroviral agents. | Non-Nucleoside Reverse Transcriptase Inhibitors | |
Calfactant | Not Available | A lung surfactant for the prophylaxis of respiratory distress syndrome in high-risk infants. | Pulmonary Surfactants / Surface-Active Agents | |
Tyloxapol | Not Available | Tyloxapol is an inhaled surfactant that assists in removing and liquefying and removing bronchopulmonary secretions with mucus and pus. Tyloxapol is administered either through nebulized solution or a stream of... | Expectorants | |
Cangrelor | 776.35 C17H25Cl2F3N5O12P3S2 | A P2Y12 platelet receptor antagonist used during percutaneous coronary intervention to reduce the risk for periprocedural myocardial infarction (MI), repeat coronary revascularization, and stent thrombosis (ST). | Platelet Aggregation Inhibitors Excl. Heparin | |
Lonafarnib | 638.822 C27H31Br2ClN4O2 | A potent farnesyl transferase inhibitor used to reduce mortality associated with Hutchinson-Gilford progeria syndrome (HGPS) and other progeroid laminopathies. | Various Alimentary Tract and Metabolism Products | |
Prucalopride | 367.87 C18H26ClN3O3 | A 5-HT4 receptor agonist indicated to treat adults with chronic idiopathic constipation. | Laxatives / Serotonin 5-HT4 Receptor Agonists / Serotonin-4 Receptor Agonist | |
Pazopanib | 437.518 C21H23N7O2S | An antineoplastic agent used in the treatment of advanced renal cell cancer and advanced soft tissue sarcoma in patients with prior chemotherapy. | Protein Kinase Inhibitors | |
Ceftaroline fosamil | 684.67 C22H21N8O8PS4 | An antibacterial agent used to treat various bacterial infections, such as acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia. | beta Lactam Antibiotics | |
Agomelatine | 243.301 C15H17NO2 | Agomelatine is indicated to treat major depressive episodes in adults. | Melatonin, agonists | |
Midostaurin | 570.649 C35H30N4O4 | An antineoplastic agent used to treat high-risk acute myeloid leukemia (AML) with specific mutations, aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematologic neoplasm (SM-AHN), or mast cell leukemia (MCL). | Protein Kinase Inhibitors | |
Panobinostat | 349.434 C21H23N3O2 | A non-selective histone deacetylase inhibitor used to treat multiple myeloma in combination with other antineoplastic agents. | Histone deacetylase (HDAC) inhibitors | |
Apixaban | 459.4971 C25H25N5O4 | An anticoagulant used for the prophylaxis of stroke and systemic embolism in nonvalvular atrial fibrillation, and deep vein thrombosis(DVT) leading to pulmonary embolism(PE), including in patients after a hip or knee replacement surgery. | Direct factor Xa inhibitors / Factor Xa Inhibitors | |
Tafenoquine | 463.501 C24H28F3N3O3 | An antiparasitic agent used for the treatment and prevention of relapse of Vivax malaria. | Aminoquinolines |
Displaying drugs 1451 - 1475 of 2778 in total